Table A5.
Number of ER+ve patients prescribed endocrine therapy by individual year since diagnosis during April–July 2015 among women recorded with ER+ve breast cancer in England during 1995–2015.
| Years since diagnosis | ER+ve patients prescribed ET | ER+ve patients |
|---|---|---|
| ≤1 | 12,844 | 21,870 |
| 1 | 19,432 | 21,512 |
| 2 | 17,361 | 19,633 |
| 3 | 14,967 | 17,257 |
| 4 | 11,439 | 13,463 |
| 5 | 5,473 | 7,746 |
| 6 | 1,599 | 3,838 |
| 7 | 881 | 3,257 |
| 8 | 507 | 3,136 |
| 9 | 341 | 2,743 |
| 10 | 224 | 2,294 |
| 11 | 167 | 2,086 |
| 12 | 131 | 1,922 |
| 13 | 105 | 1,404 |
| 14 | 50 | 638 |
| 15 | 41 | 530 |
| 16 | 48 | 421 |
| 17 | 27 | 216 |
| 18 | 24 | 147 |
| ≥19 | 31 | 127 |